Clinical Trial Update: Investigating Intracellular and Plasma Imatinib Levels in Chronic Myeloid Leukemia

View source ↗

Summary

This clinical trial update reports completion of a study evaluating intracellular and plasma levels of imatinib in patients with chronic myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Imatinib (imatinib)

Snippet

Sponsor: Brian Leber | Conditions: Chronic Myeloid Leukemia | Status: COMPLETED